Parallel approaches to the discovery of novel BRD4 inhibitors

被引：0

作者：

Jones, David H. ^{[1
]}

de Groot, Marcel J. ^{[1
]}

Heald, Robert ^{[1
]}

Arhin, Ebenezer ^{[1
]}

Goodwin, Ria ^{[1
]}

Burton, Brenda ^{[1
]}

Kulagowski, Jan ^{[1
]}

Brown, David ^{[1
]}

Irving, Steven ^{[1
]}

Bazin, Richard ^{[1
]}

Bruce, Deborah ^{[1
]}

Devos, Rene ^{[1
]}

Price, Steven ^{[1
]}

Ray, Nick ^{[1
]}

Lockey, Peter ^{[1
]}

Montana, John ^{[1
]}

Albertella, Mark R. ^{[1
]}

Green, Simon R. ^{[1
]}

机构：

[1] Argenta, Harlow, Essex, England

来源：

CANCER RESEARCH | 2014年 / 74卷 / 19期

关键词：

D O I：

10.1158/1538-7445.AM2014-5137

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5137

引用

页数：1

共 50 条

[31] Discovery of Novel BRD4 Ligand Scaffolds by Automated Navigation of the Fragment Chemical Space
Piticchio, Serena G.
Martinez-Cartro, Miriam
Scaffidi, Salvatore
Rachman, Moira
Rodriguez-Arevalo, Sergio
Sanchez-Arfelis, Ainoa
Escolano, Carmen
Picaud, Sarah
Krojer, Tobias
Filippakopoulos, Panagis
von Delft, Frank
Galdeano, Carles
Barril, Xavier
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 17887 - 17900
[32] Dual HDAC/BRD4 inhibitors against cancer
Omidkhah, Negar
Hadizadeh, Farzin
Ghodsi, Razieh
MEDICINAL CHEMISTRY RESEARCH, 2021, 30 (10) : 1822 - 1836
[33] Dual HDAC/BRD4 inhibitors against cancer
Negar Omidkhah
Farzin Hadizadeh
Razieh Ghodsi
Medicinal Chemistry Research, 2021, 30 : 1822 - 1836
[34] Design and synthesis of dual ALK/BRD4 inhibitors
Watts, Ellen
Tucker, Elizabeth
Heidenreich, David
Bellenie, Benjamin
Knapp, Stefan
Chesler, Louis
Hoelder, Swen
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
[35] Discovery of a potent, orally available tricyclic derivative as a novel BRD4 inhibitor for melanoma
Horai, Yuhei
Suda, Naoki
Uchihashi, Shinsuke
Katakuse, Mayako
Shigeno, Tomomi
Hirano, Takashige
Takahara, Junichi
Fujita, Tomoyuki
Mukoyama, Yohei
Haga, Yuji
BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 93
[36] BRD4 is a novel therapeutic target in melanoma
Segura, Miguel F.
Di Micco, Raffaella
Zhang, Guangtao
Zhang, Weijia
Osman, Iman
Zhou, Ming-Ming
Hernando, Eva
CANCER RESEARCH, 2012, 72
[37] BRD4 degradation by PROTACs represents a more effective therapeutic strategy than BRD4 inhibitors in ovarian cancer
Raina, Kanak
Lu, Jing
Qian, Yimin
Altieri, Martha
Dong, Hanging
Wang, Jing
Chen, Xin
Crew, Andrew
Coleman, Kevin
Crews, Craig
Winkler, James
CANCER RESEARCH, 2016, 76
[38] Discovery of novel trimethoxy-ring BRD4 bromodomain inhibitors: AlphaScreen assay, crystallography and cell-based assay
Chen, Zhifeng
Zhang, Hao
Liu, Shien
Xie, Yiqian
Jiang, Hao
Lu, Wenchao
Xu, Heng
Yue, Liyan
Zhang, Yuanyuan
Ding, Hong
Zheng, Mingyue
Yu, Kunqian
Chen, Kaixian
Jiang, Hualiang
Luo, Cheng
MEDCHEMCOMM, 2017, 8 (06) : 1322 - 1331
[39] DEVELOPMENT OF NANOPARTICLE-ENCAPSULATED BRD4 INHIBITORS FOR NOVEL EPIGENETIC THERAPEUTICS OF IBD
Shah, Mansi
Ma, Zonghui
Chen, Haiying
Cong, Yingzi
Zhou, Jia
Rytting, Erik
Tian, Bing
GASTROENTEROLOGY, 2023, 164 (04) : S5 - S6
[40] DEVELOPMENT OF NANOPARTICLE-ENCAPSULATED BRD4 INHIBITORS FOR NOVEL EPIGENETIC THERAPEUTICS OF IBD
Shah, Mansi
Ma, Zonghui
Chen, Haiying
Cong, Yingzi
Zhou, Jia
Rytting, Erik
Tian, Bing
INFLAMMATORY BOWEL DISEASES, 2023, 29 : S4 - S4

← 1 2 3 4 5 →